WHC is still in active development. Read this to understand our approach.
depiction of BLGXFZZNTVWLAY-UHFFFAOYSA-N.svg
isomerdesign

Methyl 17α-hydroxyyo...

Check on isomerdesign

drugmap

Yohimbine

Check on drugmap

drugmap

Yohimbine

Check on drugmap

wiki

Rauwolscine

Check on wiki

wiki

Corynanthine

Check on wiki

wiki

Yohimbine

Check on wiki

Data

InChI: InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3

Synonyms: 17alpha-hydroxy-20alpha-yohimban-16beta-carboxylic acid methyl ester, Actibine, Yohimex, 2-Hydroxy-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydro-indolo[2',3':3,4]pyrido[1,2-b]isoquinoline-1-carboxylic acid methyl ester, Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, (16alpha,17alpha)-(9CI),APHRODINE, Aphrosol, Benz[g]indolo[2,3-a]quinolizine, yohimban-16-carboxylic acid deriv., Yohimban-16-.alpha.-carboxylic acid, 17-.alpha.-hydroxy-, methyl ester, 17-Hydroxyyohimban-16-carboxylic acid methyl ester,Rauwolscine, Corynanthidine, Johimbin, Methyl 17alpha-hydroxyyohimban-16alpha-carboxylate, Baron-X, (+)-Yohimbine,Methyl (16α,17α)-17-hydroxyyohimban-16-carboxylate, Yovital, Methyl (16alpha,17alpha)-17-hydroxyyohimban-16-carboxylate, NCGC00017260-05, EINECS 205-006-9, Yohimar, Yohimbin, 17-Hydroxy-yohimbane-16-carboxylic acid methyl ester, Trans-Quinolizidine yohimbine, CHEMBL10347, Methyl (16beta,17alpha,20alpha)-17-hydroxyyohimban-16-carboxylate, Thybine, (16alpha,17alpha)-17-hydroxyyohimban-16-carboxylic acid methyl ester, (+)-Yohimbin,[3H]rauwolscine, Yohimbol-16alpha-carboxylic acid, methyl ester (6CI), Quebrachine, alpha-Yohimbine,Methyl (1R,2S,4aR,13bS,14aS)-2-hydroxy-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydroindolo[2′,3′:3,4]pyrido[1,2-b]isoquinoline-1-carboxylate, 17alpha-hydroxyyohimban-16alpha-carboxylic acid methyl ester, Quebrachin, CHEBI:48562, UNII-T4LJ7LU45W, T4LJ7LU45W, Dayto himbin, Mesoyohimbine, methyl 17alpha-hydroxy-20alpha-yohimban-16beta-carboxylate, Corynine,Methyl 17α-hydroxyyohimban-16α-carboxylate, 131-03-3, Yohimban-16alpha-carboxylic acid, 17alpha-hydroxy-, methyl ester (8CI), Yohimbic acid methyl ester, 17-alpha-Hydroxy-20-alpha-yohimban-16-beta-carboxylic acid methyl ester, Yohimban-16-alpha-carboxylic acid, 17-alpha-hydroxy-, methyl ester, 20-alpha-Yohimban-16-beta-carboxylic acid, 17-alpha-hydroxy-, methyl ester, Yohimbine (DCF), (16alpha,17alpha)-17-Hydroxy-yohimban-16-carboxylic acid methyl ester, Isoyohimbine, Aphrodyne, Yocon, Yoman

Estimated data

Solubility: -3.479 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 21.2% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.